BCG and Hippocratic AI Form Strategic Alliance to Deploy Agentic AI in Biopharma and Medtech
BCG and Hippocratic AI Announce Strategic Collaboration to Deploy Agentic AI Across Biopharma and Medtech Boston Consulting Group (BCG) and Hippocratic AI today announced a global collaboration aimed at transforming…
University of Pennsylvania, BioNTech, and OUP Unveil $50 Million Life Sciences Fund
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund The University of Pennsylvania (“Penn”), BioNTech SE (“BioNTech”), and OUP (Osage University Partners) announced the launch of the $50…
At JPM26, Policy and Politics Take Center Stage for Pharma as Biotech Outlook Brightens
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun Heading into the J.P. Morgan Healthcare Conference for the past few years, industry watchers have…
Johnson & Johnson Delivers on U.S. Agreement to Lower Costs and Invest in Manufacturing and Innovation
The agreement aims to improve medicine affordability while supporting U.S.-based manufacturing and pharmaceutical innovation. Johnson & Johnson healthcare’s leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the…
Gordian Bio Announces Collaboration with Pfizer on Obesity In Vivo Target Research
Gordian Bio Enters Research Partnership with Pfizer to Drive Obesity Target Discovery Gordian Bio, a biotechnology company pioneering large-scale in vivo functional genomics to unlock validated drug targets for chronic…
Enanta Pharmaceuticals Updates Research Pipeline and Development Strategy for 2026
Highlights recent progress across key R&D programs and outlines strategic priorities for 2026 Enanta Pharmaceuticals, Inc. a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological…
Rick R. Suarez Appointed U.S. President and Head of the BioPharmaceuticals Business Unit
The appointment strengthens leadership of the company’s U.S. BioPharmaceuticals operations and strategic growth AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals…
Candid Therapeutics Plans Phase 2 Autoimmune T-Cell Trials
Phase 2 studies advance following encouraging clinical data for T-cell engagers in autoimmune diseases Candid Therapeutics, Inc. a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through…
Bayer and Soufflé Therapeutics Partner on Heart-Targeted siRNA
Collaboration focuses on advancing cell-specific siRNA therapies for cardiovascular disease treatment. Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic…
4Moving Biotech Secures FDA IND Clearance for 4P004, Advancing Disease-Modifying Osteoarthritis Treatment
Regulatory milestone strengthens 4Moving Biotech’s leadership in osteoarthritis drug innovation 4Moving Biotech, a clinical-stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and…
Novo Nordisk’s Wegovy® Oral GLP-1 for Adult Weight Loss Now Widely Available Across the U.S.
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America Wegovy® pill is now available, providing those seeking help with their…
Japan Grants Approval for Exdensur (depemokimab) in Severe Asthma and CRSwNP Patients
Japan Approves Exdensur (depemokimab) for Severe Asthma and Nasal Polyps GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare has approved Exdensur (depemokimab) for the treatment of…